0MTD:LSE Swedish Orphan Biovitrum AB

SEK 269.40 1.60 0.597461
Icon

Swedish Orphan Biovitrum AB (0MTD:LSE) Stock Analysis and Price Targets

COMMON STOCK | | LSE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

SEK 269.40

+1.60 (+0.60)%

SEK 57.34B

N/A

N/A

N/A

Icon

0MTD:LSE

Swedish Orphan Biovitrum AB (SEK)
COMMON STOCK | LSE
SEK 269.40
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

SEK 57.34B

N/A

SEK 269.40

Swedish Orphan Biovitrum AB (0MTD:LSE) Stock Forecast

N/A

Based on the Swedish Orphan Biovitrum AB stock forecast from 0 analysts, the average analyst target price for Swedish Orphan Biovitrum AB is not available over the next 12 months. Swedish Orphan Biovitrum AB’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Swedish Orphan Biovitrum AB is Neutral, which is based on 0 positive signals and 0 negative signals. At the last closing, Swedish Orphan Biovitrum AB’s stock price was SEK 269.40. Swedish Orphan Biovitrum AB’s stock price has changed by +1.05% over the past week, +5.56% over the past month and +10.77% over the last year.

No recent analyst target price found for Swedish Orphan Biovitrum AB
No recent average analyst rating found for Swedish Orphan Biovitrum AB

Company Overview Swedish Orphan Biovitrum AB

Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia. It offers...Read More

https://www.sobi.com

Tomtebodavägen 23A, Solna, Sweden, 112 76

1,772

December

SEK

UK

Adjusted Closing Price for Swedish Orphan Biovitrum AB (0MTD:LSE)

Loading...

Unadjusted Closing Price for Swedish Orphan Biovitrum AB (0MTD:LSE)

Loading...

Share Trading Volume for Swedish Orphan Biovitrum AB Shares

Loading...

Compare Performance of Swedish Orphan Biovitrum AB Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for 0MTD:LSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Swedish Orphan Biovitrum AB (Sector: )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
0R2F:LSE
Wells Fargo & Company 0.00 (0.00%) SEK9,223,372,036.85B N/A N/A

ETFs Containing 0MTD

Symbol Name 0MTD's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Swedish Orphan Biovitrum AB (0MTD:LSE) Stock

Stock Target Advisor's fundamental analysis for Swedish Orphan Biovitrum AB's stock is Neutral.

Unfortunately we do not have enough data on 0MTD:LSE's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on 0MTD:LSE's stock to indicate what its average analyst target is.

0MTD:LSE stock's Price/Earning ratio is 18.90. Based on this 0MTD:LSE may be undervalued for its sector.

The last closing price of 0MTD:LSE's stock was SEK 269.40.

The most recent market capitalization for 0MTD:LSE is SEK 57.34B.

Unfortunately we do not have enough analyst data on 0MTD:LSE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Swedish Orphan Biovitrum AB's stock.

As per our most recent records Swedish Orphan Biovitrum AB has 1,772 Employees.

Swedish Orphan Biovitrum AB's registered address is Tomtebodavägen 23A, Solna, Sweden, 112 76. You can get more information about it from Swedish Orphan Biovitrum AB's website at https://www.sobi.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...